AI Maverick Intel Issues Initial Shares in HEAL Access Canada Acquisition, Adjusts Consideration
AI Maverick Intel Inc. issued 76.5 million shares as the first tranche for its proposed acquisition of HEAL Access Canada, adjusting total consideration from 120 million to 100 million shares and planning an uplisting to the OTCQB Venture Market.
AI Maverick Intel Inc. (OTC: AIMV) has taken a significant step forward in its proposed acquisition of HEAL Access Canada Inc., announcing the issuance of 76.5 million common shares to HEAL Group Holdings as the initial tranche of consideration under the Right of First Refusal Agreement dated Feb. 11, 2026. The company also revealed that the total consideration has been adjusted from 120 million to 100 million AIMV common shares, with both parties continuing toward a definitive agreement.
The move underscores AI Maverick Intel's strategic focus on expanding its footprint in the healthcare and artificial intelligence sectors. HEAL Access Canada is expected to complement AI Maverick's portfolio, which is centered on identifying and developing opportunities at the intersection of artificial intelligence, data platforms, and emerging technology-enabled industries. The acquisition aligns with the company's broader strategy of evaluating strategic acquisitions, partnerships, and scalable platforms designed to drive long-term shareholder value.
In addition to the acquisition progress, AI Maverick Intel has outlined plans to pursue an uplisting to the OTCQB Venture Market as part of its broader capital markets strategy. This uplisting would enhance the company's visibility and liquidity, making it more accessible to a wider range of investors. The OTCQB is a premier tier of the OTC Markets Group, requiring companies to meet higher financial standards and reporting requirements, which could bolster investor confidence.
The issuance of the initial shares marks a critical milestone in the transaction, which is expected to close upon the execution of a definitive agreement. Investors and market watchers will be closely monitoring the next steps, as the acquisition could significantly expand AI Maverick's capabilities and market reach. The company's focus on AI and data platforms positions it to capitalize on growing demand for intelligent solutions in healthcare and other sectors.
For more information on the press release, visit https://ibn.fm/mivWz. To stay updated on the latest news and developments regarding AI Maverick Intel, visit the company's newsroom at http://ibn.fm/AIMV.
The announcement comes at a time when the market is increasingly focused on AI-driven innovations and their potential to transform industries. By advancing its acquisition of HEAL Access Canada, AI Maverick Intel is positioning itself to leverage these trends and create value for its shareholders. The adjusted consideration and uplisting plans further indicate a disciplined approach to capital allocation and a commitment to enhancing corporate governance and transparency.
As the company moves toward a definitive agreement, stakeholders will be watching for further details on the strategic rationale and expected synergies of the acquisition. The transaction, if completed, could mark a new chapter for AI Maverick Intel as it seeks to establish a stronger presence in the healthcare AI space.